IDS were approached by The Binding Site (TBS) in May 2020 to provide manufacturing support for their SARS-CoV-2 antibody Elisa test which TBS had started developing in collaboration with the University of Birmingham. The team at IDS, based in Boldon UK, worked with TBS to understand the performance requirements of the test, then agree and […]